{"id":"W4229030197","doi":"10.1016/j.annonc.2022.03.197","title":"178P Assessment of side effects (SEs) impacting quality of life (QoL) in patients (pts) undergoing treatment (tx) for advanced breast cancer (ABC) in clinical practice: A real-world (RW) multi-country survey","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Novartis (Canada)","funders":"Samsung; Genentech; Plexxikon; Eisai; Seagen; MacroGenics; Astellas Pharma; Mylan; Les Laboratories Pierre Fabre; Teva Pharmaceutical Industries; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Novartis Pharmaceuticals Corporation; Celgene; AstraZeneca; Eli Lilly and Company; Genomic Health; GlaxoSmithKline","keywords":"Medicine; Quality of life (healthcare); Brief Pain Inventory; Anxiety; Breast cancer; Physical therapy; Family medicine; Internal medicine; Cancer; Chronic pain; Psychiatry; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008607161,0.000162674,0.0002065839,0.0008127228,0.0003108351,0.0005430547,0.0002019805,0.0003098619,0.002593459],"category_scores_gemma":[0.00400702,0.0001738093,0.000599178,0.001158039,0.0002055724,0.0004094769,0.0006354032,0.0005125612,0.0004016611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003186745,"about_ca_system_score_gemma":0.0003745417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004021447,"about_ca_topic_score_gemma":0.005874173,"domain_scores_codex":[0.9993545,0.0002858033,0.0001159997,0.00004746831,0.0001076298,0.00008851965],"domain_scores_gemma":[0.9965748,0.0006861262,0.001917058,0.000117674,0.000289626,0.0004147827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004369635,0.00006462571,0.9972783,0.00001638746,0.00003891355,0.00002478915,0.00006801248,0.0000333831,0.00006288086,0.000005905209,0.0001827978,0.002180323],"study_design_scores_gemma":[0.000006678855,0.0001377097,0.9991222,0.00000662333,0.00001448543,0.0001142893,0.0002090112,0.00005381682,0.00004266243,0.000005477105,0.0002846171,0.000002399751],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961479,0.0001228438,0.0000770616,0.0001128032,0.000004254048,0.00003723404,0.002249781,0.000004361392,0.001243788],"genre_scores_gemma":[0.9975781,0.0001505845,0.0002085897,0.0001083995,0.000008669434,0.00005353672,0.001429778,0.000002410001,0.0004599406],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004021447,"threshold_uncertainty_score":0.008675992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1559407936519187,"score_gpt":0.541123386923376,"score_spread":0.3851825932714573,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}